2-[4-(2,4-Dichlorophenoxy)-5-methyl-1H-pyrazol-3-yl]-5-methoxyphenol

ID: ALA5169373

Chembl Id: CHEMBL5169373

PubChem CID: 168269662

Max Phase: Preclinical

Molecular Formula: C17H14Cl2N2O3

Molecular Weight: 365.22

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2n[nH]c(C)c2Oc2ccc(Cl)cc2Cl)c(O)c1

Standard InChI:  InChI=1S/C17H14Cl2N2O3/c1-9-17(24-15-6-3-10(18)7-13(15)19)16(21-20-9)12-5-4-11(23-2)8-14(12)22/h3-8,22H,1-2H3,(H,20,21)

Standard InChI Key:  ZBEFFSDMLDFUOI-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5169373

    ---

Associated Targets(Human)

LPAR1 Tchem Lysophosphatidic acid receptor Edg-2 (779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LPAR2 Tchem Lysophosphatidic acid receptor Edg-4 (418 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LPAR3 Tchem Lysophosphatidic acid receptor Edg-7 (471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 365.22Molecular Weight (Monoisotopic): 364.0381AlogP: 5.20#Rotatable Bonds: 4
Polar Surface Area: 67.37Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.26CX Basic pKa: 1.88CX LogP: 4.76CX LogD: 4.70
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.67Np Likeness Score: -0.84

References

1. Khiar-Fernández N, Zian D, Vázquez-Villa H, Martínez RF, Escobar-Peña A, Foronda-Sainz R, Ray M, Puigdomenech-Poch M, Cincilla G, Sánchez-Martínez M, Kihara Y, Chun J, López-Vales R, López-Rodríguez ML, Ortega-Gutiérrez S..  (2022)  Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA2), UCM-14216, Ameliorates Spinal Cord Injury in Mice.,  65  (16.0): [PMID:35948083] [10.1021/acs.jmedchem.2c00046]

Source